Testosterone Cypionate Injection recalled over manufacturing violations
- Recall date
- April 10, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Eugia US LLC recalls Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC,…
- Recall number
- D-0363-2025
- FDA classification
- Class II
- Brand / firm
- Eugia US LLC
- Sold / distributed
- Nationwide USA
Why it was recalled
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01
Get recall alerts
Free email alert whenever Eugia US LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Eugia US LLC